GlaxoSmithKline Group Engineering Manager Salaries in Oklahoma City, OK
The average GlaxoSmithKline Group Engineering Manager in Oklahoma City, OK earns an estimated $203,881 annually, which includes an estimated base salary of $163,351 with a $40,531 bonus. GlaxoSmithKline's Group Engineering Manager compensation is $33,444 more than the US average for a Group Engineering Manager. Group Engineering Manager salaries at GlaxoSmithKline in Oklahoma City, OK can range from $100,000 - $490,000.
In Oklahoma City, OK, The Engineering Department at GlaxoSmithKline earns $7,207 more on average than the Marketing Department.
Last updated 2 years ago.
- $163,351
- avg. base
- $40,531
- avg. bonus
Group Engineering Manager Salaries at GlaxoSmithKline
In Oklahoma City, OK, Group Engineering Managers earn $3,001 more than Group Engineering Managers, and $9,711 less than Directors of Engineering.
Compensation at GlaxoSmithKline by Department
In Oklahoma City, OK, The Engineering Department averages $7,207 more than the Marketing Department, and $2,591 less than the Business Development Department
Group Engineering Manager Compensation by Gender (All Companies)
The average female Group Engineering Manager at companies similar size to GlaxoSmithKline reported making $161,172, while the average male Group Engineering Manager at similar sized companies reported making $208,878.
Group Engineering Manager Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Group Engineering Manager at companies similar size to GlaxoSmithKline reported making $241,524, while the average African American/Black Group Engineering Manager at similar sized companies reported making $138,333.
How Group Engineering Managers at GlaxoSmithKline Rate Their Compensation
The majority of Group Engineering Managers at GlaxoSmithKline believe they're compensated fairly. 100% of Group Engineering Managers at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline
